[1]
“Development and Validation of a Novel RP-HPLC Method for Quantification of Maralixibat, Odevixibat, and their related impurities in Pharmaceutical Formulations: Research Article”, JOPIR, vol. 3, no. 4, pp. 395–403, Aug. 2025, doi: 10.69613/m4zkjz25.